Aymeric Luzi

ORCID: 0000-0002-5984-4756
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hemodynamic Monitoring and Therapy
  • Cardiac, Anesthesia and Surgical Outcomes
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Trauma and Emergency Care Studies
  • Maternal and fetal healthcare
  • Neurosurgical Procedures and Complications
  • Cardiac Arrest and Resuscitation
  • Sepsis Diagnosis and Treatment
  • High Altitude and Hypoxia
  • Airway Management and Intubation Techniques
  • Intracranial Aneurysms: Treatment and Complications
  • Infrared Thermography in Medicine
  • Renal function and acid-base balance
  • Healthcare Systems and Practices
  • Metabolism and Genetic Disorders
  • Pain Management and Treatment
  • Anesthesia and Sedative Agents
  • Tracheal and airway disorders
  • Acute Kidney Injury Research
  • Cerebrospinal fluid and hydrocephalus
  • Treatment of Major Depression
  • Acute Ischemic Stroke Management
  • Anesthesia and Neurotoxicity Research
  • Teratomas and Epidermoid Cysts

Centre Hospitalier Universitaire de La Réunion
2020-2021

Université de Toulouse
2013-2016

Peuplements végétaux et bioagresseurs en milieu tropical
2016

Université Toulouse III - Paul Sabatier
2013-2016

Hôpital Rangueil
2016

Ospedali Riuniti di Ancona
1991

This study was design to investigate the prognostic value for death at day-28 of lactate course and clearance during first 24 hours in Intensive Care Unit (ICU), after initial resuscitation. Prospective, observational one surgical ICU a university hospital. Ninety-four patients hospitalized severe sepsis or septic shock were included. In this cohort, we measured blood concentration admission (H0) H6, H12, H24. Lactate calculated as followed: [(lactateinitial - lactatedelayed)/...

10.1186/2110-5820-3-3 article EN cc-by Annals of Intensive Care 2013-01-01

To assess the benefits and safety of early human fibrinogen concentrate in postpartum haemorrhage (PPH) management.Multicentre, double-blind, randomised placebo-controlled trial.30 French hospitals.Patients with persistent PPH after vaginal delivery requiring a switch from oxytocin to prostaglandins.Within 30 minutes introduction prostaglandins, patients received either 3 g or placebo.Failure as composite primary efficacy endpoint: at least 4 g/dl haemoglobin decrease and/or transfusion two...

10.1111/1471-0528.16699 article EN BJOG An International Journal of Obstetrics & Gynaecology 2021-03-13

Patients with good-grade subarachnoid hemorrhage (SAH) are those without initial neurological deficit. However, they can die or present severe deficit due to secondary insult leading brain ischemia. After SAH, in a known context of energy crisis, vasospasm, hydrocephalus and intracranial hypertension contribute unfavorable outcome. Lumbar puncture (LP) is sometimes performed an attempt reduce pressure (ICP) release headaches. We hypothesize that SAH patients, 20-ml LP releases headaches,...

10.1159/000339580 article EN cc-by-nc Cerebrovascular Diseases Extra 2012-09-29

Objective: To assess the benefits and safety of early human fibrinogen concentrate (FC) in postpartum haemorrhage (PPH) management. Design: Multicentre, double-blind, randomized placebo-controlled trial. Setting:30 French hospitals. Population: patients with persistent PPH after vaginal delivery requiring a switch from oxytocin to prostaglandins. Methods: Within 30 min introduction prostaglandins, received either 3 g FC or placebo. Main outcome measures: Failure as composite primary efficacy...

10.22541/au.159969769.94131642 preprint EN Authorea (Authorea) 2020-09-10

10.1016/s1074-3804(03)80147-0 article The Journal of the American Association of Gynecologic Laparoscopists 2003-08-01
Coming Soon ...